
GL Stock Forecast & Price Target
GL Analyst Ratings
Bulls say
Globe Life Inc. is poised for positive growth, with life premium growth targeted at 4.0%-4.5% and health premium estimated to rise significantly by 14%-16% in the coming year, reflecting strong demand for its insurance products. The company is actively ramping up marketing efforts, projecting a 10% increase in leads generated for its exclusive agencies, which should further drive sales across its segments. Financial performance indicators, such as a notable remeasurement gain of $150 million in the third quarter and favorable mortality experience, suggest robust operational health and support increased earnings per share estimates for 2025 and 2026.
Bears say
Globe Life Inc. has projected relatively modest operating earnings per share growth of only 3% at the midpoint for 2026, primarily influenced by significant assumption updates and a notable decrease in Life remeasurement gains from $192 million to an anticipated $50-$100 million. Additional risks include ongoing EEOC reviews related to employee allegations, increasing health utilization that may compress margins, and challenges in salesforce recruitment affecting topline growth. The underwriting margins are expected to be under pressure, particularly in the supplemental health insurance segment, where profitability is diminished by shifts toward lower-margin Medicare Supplement products.
This aggregate rating is based on analysts' research of Globe Life Inc and is not a guaranteed prediction by Public.com or investment advice.
GL Analyst Forecast & Price Prediction
Start investing in GL
Order type
Buy in
Order amount
Est. shares
0 shares